LEADER 00919nam0-22003491i-450-
001 990006948600403321
005 20130408135140.0
035   $a000694860
035   $aFED01000694860
035   $a(Aleph)000694860FED01
035   $a000694860
100   $a20010906d1963----km-y0itay50------ba
101 0 $aita
102   $aIT
105   $ay-------001yy
200 1 $aRealtà economica e monopolio$fAldo Fiaccadori
210   $aMilano$cGiuffrè$d1963
215   $a318 p.$d26 cm
610 0 $aMonopolio$aTeoria
676   $a338.82$v20$zita
700  1$aFiaccadori,$bAldo$0139482
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990006948600403321
952   $aXV G 152$b72437$fFGBC
952   $aI/2.122 FIA$b1217/I$fSES
952   $aISVE D4/3$b490$fDECTS
959   $aFGBC
959   $aSES
959   $aDECTS
996   $aRealtà economica e monopolio$935686
997   $aUNINA

LEADER 00824nam0-2200301---450-
001 990008762980403321
005 20090320085848.0
010   $a0-88167-207-6
035   $a000876298
035   $aFED01000876298
035   $a(Aleph)000876298FED01
035   $a000876298
100   $a20081121d1986----km-y0itay50------ba
101 0 $aeng
102   $aUS
105   $aa-------001yy
200 1 $aGuide to clinical interpretation of data$fBert Spilker
210   $aNew York$cRaven Press$d1986
215   $aXXVIII, 372 p.$cill.$d24 cm
676   $a615$v19
700  1$aSpilker,$bBert$095999
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990008762980403321
952   $aQ 1e 3$b2888/CB1$fDMBBM
959   $aDMBBM
996   $aGuide to clinical interpretation of data$9810464
997   $aUNINA